Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Regulatory dendritic cell therapy: From rodents to clinical application.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
PML after natalizumab discontinuation: Few and true?
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Features of Human CD3+CD20+ T Cells.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
Human endogenous retroviruses in neurologic disease.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Development and validation of the Dutch version of the London Handicap Scale.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Microglia - performers of the 21st century.
CNS Myelination Requires Cytoplasmic Dynein Function.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Measuring Water Content using T2 Relaxation at 3T: Phantom Validations and Simulations.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »